Jan 5, 2022

DMC Appoints Ashley Jenkins as CFO

5 January 2022 – DMC Biotechnologies has appointed Ashley Jenkins as Chief Financial Officer (CFO). Ashley joins DMC from Felix Energy where she has worked since 2013. Ashley joins DMC’s Boulder, Colorado office.

Ashley Jenkins has significant strategic experience in the oil and gas industry with Felix Energy and Double Eagle Petroleum Co as well as with PricewaterhouseCoopers (PWC) in Philadelphia and Denver. Ashley was VP, Controller at Felix Energy and CFO of the subsidiary Felix Water. She participated in the successful sale of over $6.0 billion in upstream, midstream and mineral assets. She was involved in corporate structure and strategy and financing facilities with loans of up to $1.5 billion.

Ashley Jenkins said, “I feel fortunate to join a strong team that has already proven the commercial viability of its first product. The DMC technology platform can bring economic and environmental cost savings across a wide range of products used in everyday goods. I’m looking forward to propelling DMC’s growth at a time when reliable and sustainable supply chains are more important than ever.”

Matt Lipscomb, Ph.D., CEO & Co-Founder of DMC said, “We are excited to welcome Ashley to the DMC team. We are expanding our leadership team and Ashley’s experience in strategic planning, financial management, M&A, governance and team building is an excellent fit.”

DMC media contact:
Kathryn Sheridan
Sustainability Consult
[email protected]

About DMC
DMC is a US biobased chemical company that makes products using microbial fermentation. Their proprietary technology simplifies biology and makes fermentation more predictable, robust, and efficient. DMC is on track to address two of the global challenges of our time: sustainably and affordably feeding a growing world population and reducing greenhouse gas emissions through efficient production of (bio)chemicals.
For more information, visit: www.dmcbio.com

Other NEWS

DMC’s Downstream Processing Proven At Scale

DMC’s Downstream Processing Proven At Scale

13 May 2021 – DMC Biotechnologies has completed downstream processing for its first product, the amino acid L-alanine. The downstream processing was done at EW Biotech in Leuna, Germany following the successful demonstration of…

read more